- Home
- HAS vs PRME Comparison
HAS vs PRME Comparison
Compare HAS & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAS
- PRME
- Stock Information
- Founded
- HAS 1923
- PRME 2019
- Country
- HAS United States
- PRME United States
- Employees
- HAS N/A
- PRME N/A
- Industry
- HAS Recreational Games/Products/Toys
- PRME Medicinal Chemicals and Botanical Products
- Sector
- HAS Consumer Discretionary
- PRME Health Care
- Exchange
- HAS Nasdaq
- PRME Nasdaq
- Market Cap
- HAS 9.6B
- PRME 191.7M
- IPO Year
- HAS N/A
- PRME 2022
- Fundamental
- Price
- HAS $74.84
- PRME $4.29
- Analyst Decision
- HAS Strong Buy
- PRME Buy
- Analyst Count
- HAS 10
- PRME 6
- Target Price
- HAS $80.70
- PRME $9.38
- AVG Volume (30 Days)
- HAS 2.5M
- PRME 5.4M
- Earning Date
- HAS 07-23-2025
- PRME 08-04-2025
- Dividend Yield
- HAS 3.73%
- PRME N/A
- EPS Growth
- HAS N/A
- PRME N/A
- EPS
- HAS 3.03
- PRME N/A
- Revenue
- HAS $4,265,300,000.00
- PRME $3,846,000.00
- Revenue This Year
- HAS $3.16
- PRME $104.12
- Revenue Next Year
- HAS $4.15
- PRME $108.24
- P/E Ratio
- HAS $24.83
- PRME N/A
- Revenue Growth
- HAS N/A
- PRME 550.76
- 52 Week Low
- HAS $49.00
- PRME $1.11
- 52 Week High
- HAS $78.83
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- HAS 58.58
- PRME 69.86
- Support Level
- HAS $75.50
- PRME $4.01
- Resistance Level
- HAS $77.83
- PRME $4.83
- Average True Range (ATR)
- HAS 1.75
- PRME 0.52
- MACD
- HAS -0.25
- PRME 0.15
- Stochastic Oscillator
- HAS 47.57
- PRME 74.82
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.